✦ LIBER ✦

Targeting VEGF, EGFR, and Other Interacting Pathways for Gastric Cancer—Promises and Reality

✍ Scribed by T. Liakakos; E. Fatourou; D. Ziogas; E. Lykoudis; Dimitrios H. Roukos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting vascular endothelial growth fa

✍ Abdel-Rahman, Omar 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 881 KB

Id-1: Regulator of EGFR and VEGF and pot

✍ Ibrahim Meteoglu, Nezih Meydan, Muhan Erkus 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 770 KB

Targeted therapy for gastric cancer: Mol

✍ Yang, Wei; Raufi, Alexander; Klempner, Samuel J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 324 KB

IS1-2 * BEYOND EGFR AND ALK INHIBITION:

✍ Wu, Y.- l. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 27 KB

Combined therapies for cancer: a review

✍ Beata Zahorowska; Philip J. Crowe; Jia-Lin Yang 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 469 KB

CUL4A ubiquitin ligase: a promising drug

✍ Sharma, P.; Nag, A. 📂 Article 📅 2014 🏛 The Royal Society 🌐 English ⚖ 754 KB